Stevanato Group S.p.A. Stock Prediction
AI-powered sentiment analysis and prediction trends for STVN, updated each market day.
STVN AI Sentiment
AI predicts Stevanato Group S.p.A. stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Stevanato Group S.p.A.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
Exchange
Market Cap
$3,753,800,792
Cap Tier
Employees
5,795
Listed Since
July 16, 2021
Website
STVN Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
STVN Volatility
Stevanato Group S.p.A. has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
